| Indication | Oncology |
| Status | FDA Final Approval |
| Product Advantages | The novel salt / formulation is designed to enhance the drug absorption by optimizing the bioavailability and therefore decrease dose intake as well as concentration variability. The food effect is also eliminated and OMCAZIO can be co-administered with food. |
| Potential Market | The branded drug is a multi-target oncological therapy indicated for the treatment of various malignancies, with a significant potential market. According to the 2025 annual report from the branded drug company, net revenue from the U.S. market in 2025 amounted to USD 2.83 billion. |
?
R&D
OMCAZIOTM
